News & Updates

Thank you again to all the attendees and organizers at SCOPE Summit for making the conference a huge success!

02/25/2020

We met incredible researchers, partners, and solution providers at the event, and thanks to our on the ground team Christopher Kata, Heather Williams, and Chris Hamelin, we were able to engage with them using our recently released eClinical Technology interoperability diagram that maps out TrialStat’s innovative advances in Trial Management Technology, Vendor Neutral Imaging Archive,…

Read More

Data and Digital takeaways from J.P. Morgan 2020

02/06/2020

Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development, wrote a very succinct summary of the core topics covered at J.P. Morgan 2020. We’re excited to see the continued momentum behind these digital trends and how we’re enabling Sponsors to take advantage of Real World Data, Machine Learning and so much more through…

Read More

World first as drug developed using AI enters clinical trials

02/03/2020

This may just be the first drug to be generated using artificial intelligence (AI) which has now entered clinical trials in Japan. “The project has been particularly heralded for the speed it took to complete – taking just 12 months when compared to the typical five years it takes drug companies to complete the research…

Read More

Microsoft takes the wraps off $40 million, five-year ‘AI for Health’ initiative

02/01/2020

Microsoft has recently announced a $40 Million investment in AI for Health Initiatives. “Through its AI for Good projects, Microsoft is applying lessons from software to artificial intelligence technologies that are under development. In the case of health, Microsoft officials said their mission is to use insights derived from AI technologies and techniques to search…

Read More

A single number helps Stanford data scientists find most dangerous cancer cells

01/29/2020

“Biomedical data scientists at the Stanford University School of Medicine have shown that the number of genes a cell uses to make RNA is a reliable indicator of how developed the cell is, a finding that could make it easier to target cancer-causing genes.” Click the button below to read the entire Article! Continue Reading…

Read More

SOSV Announces Launch of IndieBio New York

01/08/2020

A fantastic opportunity for life science startups in the New York area! “We’re doubling down on life sciences,” said Sean O’Sullivan, Managing General Partner of SOSV. “We are looking to bring what IndieBio has created for the California life science industry to the East Coast. New York is a great hub for life sciences research and financing, and will be…

Read More

Google Shows AI Can Spot Breast Cancer Better Than Doctors

01/06/2020

According to new research from Google Health, AI can more accurately detect breast cancer than physicians. “The technology’s reading of mammograms reduced both false positives, where healthy patients are mistakenly diagnosed with the disease, and false negatives, where the cancer is missed, the Alphabet Inc. unit said in a blog post on Wednesday. The system reduced false positives by…

Read More

New radiotracer offers opportunities for earlier intervention after heart attack

01/06/2020

“ Reston, VA–Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage. According to research published in the December issue of The Journal of Nuclear Medicine, 68Ga-FAPI-04 positron emission tomography (PET) can effectively image fibroblast activation after myocardial…

Read More

Meet with Christopher Kata and the TrialStat team (booth # 701), during SCOPE – Summit for Clinical Operations Execs, February 18th – 21st, in Orlando, Florida!

01/02/2020

Meet with Christopher Kata, Director of Sales & Marketing February 18th – 21st, 2020 at the SCOPE – Summit for Clinical Operations Executives in Orlando, Florida. Christopher and the TrialStat team are exhibiting in booth # 701. Christopher Kata, Director of Sales & Marketing905 999-1957ckata@trialstat.com Event: SCOPE – Summit for Clinical Operations Executives When: February…

Read More

Meet with Christopher Kata, during the MedTeq Innovation Summit in Montreal, Quebec.

01/02/2020

Meet with Christopher Kata, Director of Sales & Marketing January 13th to the 16th 2020 at the MedTeq Innovation Summit in Montreal, Quebec. Christopher Kata, Director of Sales & Marketing905 999-1957ckata@trialstat.com Event: MedTeq Innovation Summit When: January 13th – 16th, 2020 Where: Grand Quai du Port de Montréal, 200 de la Commune West Street, Montreal…

Read More